These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9307261)

  • 21. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
    Cushman M; Rosendaal FR; Psaty BM; Cook EF; Valliere J; Kuller LH; Tracy RP
    Thromb Haemost; 1998 May; 79(5):912-5. PubMed ID: 9609219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia.
    Johnson SM; Meyers RL
    J Pediatr Surg; 2001 Aug; 36(8):1146-9. PubMed ID: 11479844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke].
    Pongrácz E; Tordai A; Csornai M; Béla Z; Nagy Z
    Ideggyogy Sz; 2003 May; 56(5-6):157-64. PubMed ID: 12861956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brain stem ischemia in a boy with resistance to C activated protein and elevated lipoprotein A].
    Sameiro-Barreirinho M; Costa E; Moreira A; Barbot J; Barbot C; Santos M
    Rev Neurol; 1999 Jun 1-15; 28(11):1061-4. PubMed ID: 10390775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
    Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
    Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antenatal screening for factor V Leiden mutation: a critical appraisal.
    Rouse DJ; Goldenberg RL; Wenstrom KD
    Obstet Gynecol; 1997 Nov; 90(5):848-51. PubMed ID: 9351777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemiplegic cerebral palsy and the factor V Leiden mutation.
    Halliday JL; Reddihough D; Byron K; Ekert H; Ditchfield M
    J Med Genet; 2000 Oct; 37(10):787-9. PubMed ID: 11183183
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor V Leiden is not common in children with portal vein thrombosis.
    Seixas CA; Hessel G; Ribeiro CC; Arruda VR; Annichino-Bizzacchi JM
    Thromb Haemost; 1997 Feb; 77(2):258-61. PubMed ID: 9157577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 34. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral palsy in siblings caused by compound heterozygous mutations in the gene encoding protein C.
    Fong CY; Mumford AD; Likeman MJ; Jardine PE
    Dev Med Child Neurol; 2010 May; 52(5):489-93. PubMed ID: 20187890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor V Q 506 mutation in children with thrombosis.
    Gurgey A; Mesci L; Renda Y; Olcay L; Kocak N; Erdem G
    Am J Hematol; 1996 Sep; 53(1):37-9. PubMed ID: 8813095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy.
    Harum KH; Hoon AH; Kato GJ; Casella JF; Breiter SN; Johnston MV
    Dev Med Child Neurol; 1999 Nov; 41(11):777-80. PubMed ID: 10576642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor V Leiden associated with flap loss in microsurgical breast reconstruction.
    Khansa I; Colakoglu S; Tomich DC; Nguyen MD; Lee BT
    Microsurgery; 2011 Jul; 31(5):409-12. PubMed ID: 21503971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal stroke in a neonate heterozygous for factor V Leiden mutation.
    Verdu A; Cazorla MR; Moreno JC; Casado LF
    Brain Dev; 2005 Sep; 27(6):451-4. PubMed ID: 16122636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated protein C resistance due to a factor V mutation associated with familial ischemic stroke.
    De Lucia D; Nina P; Papa ML; Belli A; Conte M; Renis V; Di Mauro C; Masi S; Franco A; Schisano G
    J Neurosurg Sci; 1997 Dec; 41(4):373-8. PubMed ID: 9555645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.